Analysis of Clinical Characteristics and Prognosis of Patients With Periocular Malignant Melanoma in Korea

• Published in: The Journal of craniofacial surgery Vol. 32; no. 8; p. 2716
• Main Authors: Park, Na Ri, Kim, Sung Eun, Jung, Su-Kyung, Yang, Suk Woo
• Format: Journal Article
• Language: English
• Published: United States 01.11.2021
• Subjects: Humans; Melanoma; Neoplasm Recurrence, Local; Prognosis; Republic of Korea - epidemiology; Retrospective Studies; Survival Rate; Republic of Korea
• ISSN: 1536-3732
• DOI: 10.1097/SCS.0000000000007800

To report the clinical features of 20 patients with malignant melanoma and to evaluate the survival and prognosis of patients with malignant melanoma in Korea. The medical records of 20 patients with malignant melanoma treated between March 2004 and March 2020 were reviewed retrospectively. The demographic data, clinical characteristics, and outcomes were also reviewed. Outcome measures included local recurrence, metastasis, and tumor-related mortality. Prognostic factors associated with recurrence, metastasis, and survival were analyzed using a Cox proportional hazards model. Among the 20 patients with periocular malignant melanoma, 4 (20%) showed local recurrence during follow-up (6.61 ± 6.36 years). The 1-, 5-, and 10-year recurrence rates were 5%, 10.3%, and 24.1%, respectively. 10 (50%) patients developed distant metastasis, mainly involving lung, brain, parotid gland and spine. The 1-, 5-, and 10-year rates of metastasis were 5%, 10.9%, and 35.7%, respectively. Significantly fewer metastases were detected following initial extensive surgical excision (P = 0.04). 8 (40%) patients died of malignant melanoma. The main risk factor for mortality was tumor thickness (HR: 3.88, P < 0.01). Based on Kaplan-Meier survival estimates, the 1-, 5-, and 10-year tumor-related survival rates were 75.8%, 55.6%, and 55.6%, respectively. Tumor thickness is a significant prognostic factor affecting the survival rate. It is important to reduce the metastatic rate via extensive resection without leaving any residual tumor in the margin during surgery.